News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News CRT 2021 DOAC Use Increasing in Patients With Bioprosthetic Heart Valves Todd Neale March 08, 2021
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Conference News SCAI 2019 ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3 Yael L. Maxwell June 05, 2019
News Daily News Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works Shelley Wood April 16, 2019
News Daily News New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry Caitlin E. Cox November 30, 2017
Presentation TVT 2017 The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy Presenter: Martin B. Leon, Hendrik Treede, George D. Dangas June 16, 2017
News Daily News Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry Michael O'Riordan December 19, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Daily News Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas Shelley Wood September 13, 2016
Presentation TCT 2014 Adjunctive Pharmacotherapy During and After TAVR: BRAVO 3 and Beyond Presenter: George D. Dangas September 16, 2014
Presentation TCT 2014 TAVR Gulf Experience and a Difficult TAVR Case Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Mohammed Balghith September 16, 2014
Presentation TCT 2014 Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD) Presenter: Blase A. Carabello, George D. Dangas September 15, 2014
Presentation TCT 2014 TAVR On the Horizon: Emerging TAVR Platforms and Technologies Presenter: Blase A. Carabello, George D. Dangas, Lutz Buellesfeld September 15, 2014
Presentation TCT 2014 TAVR Update: FDA-Approved Valve Systems Presenter: Blase A. Carabello, George D. Dangas, Alan C. Yeung September 15, 2014
Presentation TCT 2014 Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara September 15, 2014
Presentation TCT 2014 TAVR in a High-Risk Woman with Difficult Vascular Access Presenter: Thierry Corcos, George D. Dangas, Ahmed Magdy, Raj Makkar September 13, 2014